1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Clinical characteristics of children with Angelman syndrome in this study
Characteristic Angelman Syndrome (n = 14) Age (months) 95.9 ± 57.8 (range, 3–18 years) Sex (male:female) 7:7 Genetic mutation UBE3A (15q11-q13 deletions) 13 Paternal UPD 1 Seizure 10 (71.4%) Use of at least 1 meaningful word 5 (35.7%) Walking alone 11 (78.6%) Ataxia or tremor 10 (71.4%) Strabismus 5 (35.7%) Ataxia and unable to walk alone 3 (21.4%) Ataxia but walking alone 7 (50.0%) No ataxia (walking alone) 4 (28.6%)
Note: UPD indicates uniparental disomy.